Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Antibody Drug Conjugates Market Evolve in Terms of Growth and Size by 2029?

The market for antibody drug conjugates has witnessed a remarkable expansion in the recent past. The market, which stands at $13.57 billion in 2024, is projected to escalate to $16.53 billion by 2025, reflecting a compound annual growth rate (CAGR) of 21.8%. Factors such as an upward trend in cancer cases, successful clinical trials and approvals, strategic partnerships, escalating investment in research and development, and market widening strategies have predominantly contributed to the historical growth.

Growth projections for the antibody drug conjugates market predict a rapid expansion in size in the forthcoming years. The market is projected to escalate to “$37.9 billion by 2029, with a yearly growth rate of 23.1%.” This significant growth during the forecast period is likely due to factors such as the development of next-generation ADCs, broadening indications, a growing emphasis on personalized medicine, increasing investment in precision medicine, and a general rise in healthcare awareness. Upcoming trends for the forecast period encompass progress in conjugation technologies, an enhanced understanding of tumor biology, technological innovations, an expansion in therapeutic application, and advancements in conjugation technologies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2569&type=smp

What factors are expected to fuel Antibody Drug Conjugates market growth in the coming years?

The global escalation in cancer cases is propelling the market for antibody-drug conjugates. The primary factors contributing to the prevalence of most cancers are obesity, smoking, alcohol consumption, and unhealthy eating patterns. According to Cancer Research UK, annual new cancer cases are projected to reach 27.5 million by 2040. As the occurrences of cancer continue to rise, it is expected to heighten the need for antibody-drug conjugates, thereby fostering the expansion of the market.

The antibody drug conjugates market covered in this report is segmented –

1) By Type: Monoclonal Antibodies, Linker, Drug/Toxin, Other Types

2) By Product: Adcertis, Kadcyla, Other Products

3) By Technology: Immunogen Technology, Seattle Genetics Technology, Immunomedics Technology, Other Technology

4) By Application: Blood Cancer, Breast Cancer, Ovarian Cancer, Lung Cancer, Brain Tumor, Other Applications

5) By End User: Hospital, Clinics, Other End Users

Subsegments:

1) By Monoclonal Antibodies: IgG-based Monoclonal Antibodies, IgM-based Monoclonal Antibodies, Bispecific Antibodies

2) By Linker: Cleavable Linkers, Non-cleavable Linkers, Stable Linkers

3) By Drug/Toxin: Cytotoxic Drugs, Chemotherapeutic Agents, Radioisotopes

4) By Other Types: Enzyme-Targeted ADCs, Antibody-Drug Conjugates with Immune Modulators

Which Trends Are Redefining The Future Landscape Of The Antibody Drug Conjugates Industry?

Regulatory authorities like the Food and Drug Administration in the USA oversee the manufacturing of antibody-drug conjugates. While there is no specific ADC development guidance in the USA, the FDA employs pre-existing guidelines for small drugs and monoclonal antibodies to exercise control. The FDA’s product quality departments, including the Office of Biotechnology Products (OBP) and Office of Pharmaceutical Quality, focus mainly on the production and control plan for the antibody part of the ADC, and the drug substance (DS) and drug product (DP). The job of assessing the payload and linker’s sufficiency, conjugation reactions, and control strategy aspects lies primarily with the small molecule review groups of the Office of Pharmaceutical Quality.

What Are The Most Active Companies In The Antibody Drug Conjugates Market Today?

Major companies operating in the antibody drug conjugates market include Pfizer Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., AstraZeneca plc, Takeda Pharmaceutical Company Limited, Millennium Pharmaceuticals Inc., Gilead Sciences Inc., Daiichi Sankyo Company Limited, Sorrento Therapeutics Inc., Astellas Pharma Inc., Zydus Lifesciences Limited, Seagen Inc., Seagen Inc., Synthon BV, Genentech Inc., ImmunoGen Inc., Nordic Nanovector ASA, ADC Therapeutics SA, Immunomedics Inc., Mersana Therapeutics Inc., Heidelberg Pharma AG, Celldex Therapeutics Inc., Oxford BioTherapeutics, Concortis Biotherapeutics Corp., Antikor BioPharma Ltd., Eisai Co. Ltd., Merck KGaA

https://www.thebusinessresearchcompany.com/report/antibody-drug-conjugates-global-market-report

Which Regional Markets Are Attracting The Most Investment In Antibody Drug Conjugates?

North America was the largest region in the antibody-drug conjugates (ADCs) market in 2024. The Middle East is expected to be the fastest-growing region in the global antibody drug conjugates market share during the forecast period. The regions covered in the antibody drug conjugates market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=2569&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model